Back
INmune Bio Vs. Dave Industry Stock Comparison
Sell
45
INMB
INmune Bio
Last Price:
$5.40
Seasonality Move:
-17.41%
Buy
85
DAVE
Dave
Last Price:
$90.94
Seasonality Move:
87.09%
Sell
45
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $5.30. The Score for INMB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $5.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INMB is experiencing selling pressure, which indicates risk of future bearish movement.
DAVE Stock Price Chart
INMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 58.42 | Buy |
Chaikin Money Flow: | 158850 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.2 | Buy |
Relative Strength Index (14 RSI): | 53.45 | Buy |
Chaikin Money Flow: | -52588 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.01 - 96.95) | Sell |
Bollinger Bands (100): | (33.96 - 82.02) | Buy |
INMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.75 | Buy |
20-day SMA: | 4.84 | Buy |
50-day SMA: | 5.22 | Buy |
200-day SMA: | 7.54 | Sell |
8-day EMA: | 4.85 | Buy |
20-day EMA: | 4.86 | Buy |
50-day EMA: | 5.13 | Buy |
200-day EMA: | 6.9 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.98 | Sell |
20-day SMA: | 91.47 | Sell |
50-day SMA: | 76.51 | Buy |
200-day SMA: | 48.32 | Buy |
8-day EMA: | 91.11 | Buy |
20-day EMA: | 89.97 | Buy |
50-day EMA: | 78.92 | Buy |
200-day EMA: | 51.57 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.18 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $1.12 per share.
INmune Bio Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |